DPYD Genotype-Guided Fluoropyrimidine Dosing: FDA and NCCN Updates to Guide 5-FU and Capecitabine Dosing for Oncologists
DPYD Genotype-Guided Fluoropyrimidine Dosing: FDA and NCCN Updates to Guide 5-FU and Capecitabine Dosing for Oncologists. A continuing education activity offered by ARUP Institute for Learning.
